Cargando…

Potential Use of CTCs as Biomarkers in Renal Cancer Patients

We demonstrated that the CellCollector is an appropriate tool for detecting CTCs in RCC patients. We examined EpCAM and MUC1 expression levels in RCC tissues and cell lines and analyzed the detection rate of CTCs in blood samples ex vivo using an anti-EpCAM antibody-covered straight or spiraled Cell...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bialek, Joanna, Wencker, Andreas, Kawan, Felix, Yankulov, Stefan, Fornara, Paolo, Theil, Gerit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779819/ https://www.ncbi.nlm.nih.gov/pubmed/35054482 http://dx.doi.org/10.3390/life12010089

Ejemplares similares

Role of Nivolumab in the Modulation of PD-1 and PD-L1 Expression in Papillary and Clear Cell Renal Carcinoma (RCC)
por: Bialek, Joanna, et al.
Publicado: (2022)

Differential Expression of the Androgen Receptor, Splice Variants and Relaxin 2 in Renal Cancer
por: Bialek, Joanna, et al.
Publicado: (2021)

Association of Circulating Tumor Cells with Inflammatory and Biomarkers in the Blood of Patients with Metastatic Castration-Resistant Prostate Cancer
por: Theil, Gerit, et al.
Publicado: (2021)

Position of Circulating Tumor Cells in the Clinical Routine in Prostate Cancer and Breast Cancer Patients
por: Theil, Gerit, et al.
Publicado: (2020)

In vivo isolation of circulating tumor cells in patients with different stages of prostate cancer
por: Theil, Gerit, et al.
Publicado: (2021)

Strategies for Isolating and Propagating Circulating Tumor Cells in Men with Metastatic Prostate Cancer
por: Theil, Gerit, et al.
Publicado: (2022)

The Adipocyte-Derived Hormone Leptin Has Proliferative Actions on Androgen-Resistant Prostate Cancer Cells Linking Obesity to Advanced Stages of Prostate Cancer
por: Hoda, M. Raschid, et al.
Publicado: (2012)

The Use of a New CellCollector to Isolate Circulating Tumor Cells from the Blood of Patients with Different Stages of Prostate Cancer and Clinical Outcomes - A Proof-of-Concept Study
por: Theil, Gerit, et al.
Publicado: (2016)

Correction: Extract from Cucurbita pepo improves BPH symptoms without affecting sexual function: a 24-month noninterventional study
por: Theil, Gerit, et al.
Publicado: (2022)

Extract from Cucurbita pepo improves BPH symptoms without affecting sexual function: a 24-month noninterventional study
por: Theil, Gerit, et al.
Publicado: (2022)

Circulating tumor cells (CTCs) and hTERT gene expression in CTCs for radiotherapy effect with lung cancer
por: Xu, Ying, et al.
Publicado: (2023)

Apoptotic circulating tumor cells (CTCs) in the peripheral blood of metastatic colorectal cancer patients are associated with liver metastasis but not CTCs
por: Allen, Joshua E., et al.
Publicado: (2013)

The Prognostic Role of Circulating Tumor Cells (CTCs) in Lung Cancer
por: Kapeleris, Joanna, et al.
Publicado: (2018)

Are Circulating Tumor Cells (CTCs) Ready for Clinical Use in Breast Cancer? An Overview of Completed and Ongoing Trials Using CTCs for Clinical Treatment Decisions
por: Schochter, Fabienne, et al.
Publicado: (2019)

ERBB signaling in CTCs of ovarian cancer and glioblastoma
por: Geethadevi, Anjali, et al.
Publicado: (2017)

Liquid Biopsy in Lung Cancer: Clinical Applications of Circulating Biomarkers (CTCs and ctDNA)
por: Lim, Minji, et al.
Publicado: (2018)

CTCs Expression Profiling for Advanced Breast Cancer Monitoring
por: Pereira-Veiga, Thais, et al.
Publicado: (2019)

DNA hypomethylation silences antitumor immune genes in early prostate cancer and CTCs
por: Guo, Hongshan, et al.
Publicado: (2023)

Challenges in enumeration of CTCs in breast cancer using techniques independent of cytokeratin expression
por: Castle, John, et al.
Publicado: (2017)

CD74 and CD44 Expression on CTCs in Cancer Patients with Brain Metastasis
por: Loreth, Desiree, et al.
Publicado: (2021)

Molecular characterization of breast cancer CTCs associated with brain metastasis
por: Boral, Debasish, et al.
Publicado: (2017)

The Mechanical Fingerprint of Circulating Tumor Cells (CTCs) in Breast Cancer Patients
por: Nel, Ivonne, et al.
Publicado: (2021)

CTCs 2020: Great Expectations or Unreasonable Dreams
por: Rossi, Elisabetta, et al.
Publicado: (2019)

Expression of GP88 (progranulin) in serum of prostate cancer patients is associated with Gleason scores and overall survival
por: Greither, Thomas, et al.
Publicado: (2018)

Detection of circulating tumor cells (CTCs) in cerebrospinal fluid of a patient with HER2-overexpressing gastric cancer and single cell analysis of intra-patient heterogeneity of CTCs
por: Cho, Jang Ho, et al.
Publicado: (2019)

Circulating Tumor Cells (CTCs): A Unique Model of Cancer Metastases and Non-invasive Biomarkers of Therapeutic Response
por: Liu, Jialing, et al.
Publicado: (2021)

Evaluation of α-tubulin, detyrosinated α-tubulin, and vimentin in CTCs: identification of the interaction between CTCs and blood cells through cytoskeletal elements
por: Kallergi, G., et al.
Publicado: (2018)

EMT and EGFR in CTCs cytokeratin negative non-metastatic breast cancer
por: Serrano, Maria J., et al.
Publicado: (2014)

Current Status of CTCs as Liquid Biopsy in Lung Cancer and Future Directions
por: Zhang, Zhuo, et al.
Publicado: (2015)

Gauging the Impact of Cancer Treatment Modalities on Circulating Tumor Cells (CTCs)
por: Mathias, Trevor J., et al.
Publicado: (2020)

PARP-1 Expression and BRCA1 Mutations in Breast Cancer Patients’ CTCs
por: Sklias, Thodoris, et al.
Publicado: (2022)

EMT, CTCs and CSCs in tumor relapse and drug-resistance
por: Mitra, Abhisek, et al.
Publicado: (2015)

Combinatorial Power of cfDNA, CTCs and EVs in Oncology
por: Keup, Corinna, et al.
Publicado: (2022)

Ex vivo expansion of circulating tumour cells (CTCs)
por: Mohamed, Bashir M., et al.
Publicado: (2023)

Artificial Intelligence Based on Blood Biomarkers Including CTCs Predicts Outcomes in Epithelial Ovarian Cancer: A Prospective Study
por: Ma, Jun, et al.
Publicado: (2021)

Dangerous Liaisons: Circulating Tumor Cells (CTCs) and Cancer-Associated Fibroblasts (CAFs)
por: Hurtado, Pablo, et al.
Publicado: (2020)

Telomerase positive CTCs with PSMA high expression associated with prostate cancer metastasis
por: Yang, Zhenrong, et al.
Publicado: (2022)

Quantification and Characterization of CTCs and Clusters in Pancreatic Cancer by Means of the Hough Transform Algorithm
por: Calero-Castro, Francisco José, et al.
Publicado: (2023)

The prognostic value of circulating tumour cells (CTCs) and CTC white blood cell clusters in patients with renal cell carcinoma
por: Guan, Yibing, et al.
Publicado: (2021)

Pure CTCs, advanced WGS, and precise personalized combination therapies
por: Peters, Brock A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_doof3eol8irfhuaahec9ij8sja